Gene alterations in PAX5, including deletions, point mutations, and amplifications, occur in approximately 30% of B‐ALL cases, and chromosomal rearrangements account for 2–3% [6, 7, 8]. The gene discussed is PAX5; the disease is acute lymphoblastic leukemia.